Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. influenza human
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Influenza Human Articles & Analysis

7 news found

H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

Some isolated influenza A viruses cause severe disease in poultry and, in rare cases, in humans. Sometimes the virus is transmitted from wild waterfowl to poultry, which can lead to outbreaks or cause human influenza pandemics. H5N1 is a subtype of influenza A virus and belongs to the genus Alpha ...

ByCreative Diagnostics


AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook

AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook

The company also provided the outlook for 2022 across its pipeline of allogeneic, off-the-shelf, virus-specific T cell (VST) therapies for immunocompromised patients, including its lead product posoleucel, an investigational VST in development for the treatment and prevention of infections and diseases caused by six common devastating viruses – adenovirus (AdV), BK virus (BKV), ...

ByKalaris


Atriva Therapeutics receives U.S. FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

Atriva Therapeutics receives U.S. FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

These RNA viruses may lead to serious diseases in humans with a high risk of fatality and have been classified by the CDC as a potential bioterrorism ...

ByAtriva Therapeutics GmbH


FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation

Separately, the company also announced the initiation of a Phase 1/2 clinical trial (NCT04933968) of ALVR106, its investigational, allogeneic, off-the-shelf, multi-VST therapy for the treatment of infections caused by human metapneumovirus (hMPV), influenza, parainfluenza virus (PIV) and respiratory syncytial virus (RSV). ...

ByKalaris


Universal flu vaccine pioneer EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

Universal flu vaccine pioneer EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

The unique genetic nature of the influenza virus poses a challenge to researchers focused on influenza treatment and vaccination. ...

ByEnGen Bio LLC


EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent need in its Global Influenza Strategy (2019–2030) report. The unique nature and genetic makeup of the influenza virus poses a challenge to researchers focused on ...

ByEnGen Bio LLC


Imaxio receives scientific advice from the European Medicines Agency (EMA) for its influenza vaccine candidate IMX836

Imaxio receives scientific advice from the European Medicines Agency (EMA) for its influenza vaccine candidate IMX836

Imaxio, a biotech company specializing in immunology, announces today that it has received scientific advice from the European Medicines Agency (EMA) for IMX836, its vaccine candidate dedicated to the prevention of influenza in humans. This first scientific advice reinforces Imaxio’s plan to start, by early 2018, a phase I clinical trial involving IMX836. ...

ByIMAXIO S.A.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT